Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Standard

Red cell distribution width

TMPRSS6 · rs228910

Strength of the evidence

2 / 4

Its strongest genetic-study result is p = 10−22, with 1 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 408,112 British individuals.

The effect Each copy of the G allele shifted the measure 0.0271 higher (95% confidence interval 0.022-0.033); p = 2 × 10−22.

How common The G allele had a frequency of about 62% in the people studied.

Where it sits Chromosome 22, band 22q12.3 — in an intron of TMPRSS6.

How common each version is

AG
Korean KRGDB
A 48.4% · G 51.6%
Korean Korea4K
A 47.2% · G 52.8%
Korean Korea1K
A 46.4% · G 53.6%
Japanese ToMMo
A 43.5% · G 56.5%
Vietnamese
A 54.3% · G 45.7%
World gnomAD
A 41.1% · G 58.9%
World 1000 Genomes
A 47.3% · G 52.7%
World TOPMed
A 40.7% · G 59.3%

By ancestry gnomAD

East Asian
A 51.6% · G 48.4%
European (non-Finnish)
A 39.8% · G 60.2%
African / African American
A 37.3% · G 62.7%
South Asian
A 63.8% · G 36.2%
Admixed American (Latino)
A 45.5% · G 54.5%
Middle Eastern
A 46.3% · G 53.7%
Finnish
A 42.5% · G 57.5%
Ashkenazi Jewish
A 40.3% · G 59.7%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. The ancestry rows are gnomAD's own groups (via Ensembl), as the survey defines them, not races.

What each result means

A/A No copy of the version the research linked to Red cell distribution width. This is the starting point the study compared everyone against.
A/G One copy of the version the research linked to Red cell distribution width. That is a smaller link than two copies.
G/G Two copies of the version the research linked to Red cell distribution width. That is the strongest link of the three results. A link in a study is not a diagnosis.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Red cell distribution width (rs228910). MyGeneLog™. https://www.mygenelog.com/variants/rs228910

← See all variants